Expedited discovery of second generation NK-1 antagonists: Identification of a nonbasic aryloxy substituent

Solution-phase. parallel-synthesis techniques were used to optimize a series of nonbasic NK-I antagonists, resulting in the identification of (R)-26, an orally bioavailable compound with subnanomolar potency, (C) 2001 Elsevier Science Ltd. All rights reserved.